Magnesium Sulfate; Potassium Chloride; Sodium Sulfate Patent Expiration
Magnesium Sulfate; Potassium Chloride; Sodium Sulfate is Used for preparing the colon for colonoscopy. It was first introduced by Braintree Laboratories Inc
Magnesium Sulfate; Potassium Chloride; Sodium Sulfate Patents
Given below is the list of patents protecting Magnesium Sulfate; Potassium Chloride; Sodium Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Sutab | US10143656 | Solid oral sulfate salt formulations for cleaning a colon and methods of using same | Aug 04, 2037 | Braintree Labs |
| Sutab | US11033498 | Solid oral sulfate salt formulations for cleaning a colon and methods of using same | Aug 04, 2037 | Braintree Labs |
| Sutab | US11382864 | Solid oral sulfate salt formulations for cleansing a colon and methods of using same | Aug 04, 2037 | Braintree Labs |
| Sutab | US11638697 | Solid oral sulfate salt formulations for cleaning a colon and methods of using same | Aug 04, 2037 | Braintree Labs |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Magnesium Sulfate; Potassium Chloride; Sodium Sulfate's patents.
Latest Legal Activities on Magnesium Sulfate; Potassium Chloride; Sodium Sulfate's Patents
Given below is the list recent legal activities going on the following patents of Magnesium Sulfate; Potassium Chloride; Sodium Sulfate.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Mail Miscellaneous Communication to Applicant | 03 May, 2023 | US11638697 |
| Recordation of Patent eGrant | 02 May, 2023 | US11638697 |
| Recordation of Patent Grant Mailed | 02 May, 2023 | US11638697 |
| Patent Issue Date Used in PTA Calculation | 02 May, 2023 | US11638697 |
| Miscellaneous Communication to Applicant - No Action Count | 02 May, 2023 | US11638697 |
| Issue Notification Mailed | 12 Apr, 2023 | US11638697 |
| Application Is Considered Ready for Issue | 29 Mar, 2023 | US11638697 |
| Dispatch to FDC | 29 Mar, 2023 | US11638697 |
| Issue Fee Payment Received | 17 Mar, 2023 | US11638697 |
| Issue Fee Payment Verified | 13 Mar, 2023 | US11638697 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳